With the addition of sophisticated new technology, our Intensity Modulated Radiation Therapy (IMRT), Stereotactic Radiosurgery (SRS), and Stereotactic Radiotherapy (SRT) programs have been expanded, and we now offer Image Guided Radiation Therapy (IGRT) and Stereotactic Body Radiotherapy (SBRT) programs.
IMRT: The current state-of-the-art delivery of external beam radiotherapy. It provides the best quality radiotherapy in terms of optimal dose delivery to the target while limiting the dose to nearby normal tissues. In 2010, RapidArc® radiotherapy technology was added to our system. This new element improves dose conformity while significantly shortening treatment times. RapidArc delivers treatments two to eight times faster than previously possible, thereby increasing precision—a combination that enables physicians to improve the standard of care. For more information on RapidArc™ radiotherapy technology, click here.
IGRT: With the On-Board Imager (OBI) upgrade, image-guided radiation therapy (IGRT) is now utilized by clinicians to offer advanced imaging techniques, which verify patient position and tumor position at the time of treatment. Knowing exactly where the tumor is allows clinicians to reduce the volume of tissue that receives radiation, targeting only the tumor and sparing the surrounding normal tissue.
SRS: An advanced form of radiation therapy that uses stereotactic localization and high energy x-ray beams to arrest the growth of a brain tumor. SRS delivers a large dose of radiation on a single day.
SRT: An advanced form of radiation therapy that uses stereotactic localization and high energy x-ray beams given over several days to arrest the growth of a tumor. Brain tumors that are too large for SRS (> 3 cm) may be treated by SRT.
SBRT: A technique that delivers high radiation doses to tumors located in areas other than the brain in a hypo-fractionated schedule, usually 2-5 treatments over a one-to two-week period, without increasing complications compared to conventional radiotherapy. SBRT is an excellent alternate choice of treatment for patients with medically inoperable tumors, elderly patients who are considered high risk for surgery, or patients who refuse surgical treatment.